MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
COMPLETEDNCT00004230·PHASE3·Northwestern University·35 enrolled
captoprilcyclophosphamideautologous bone marrow transplantationperipheral blood stem cell transplantationradiation therapy
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
COMPLETEDNCT00004241·PHASE1·National Cancer Institute (NCI)·60 enrolled
tanespimycinpharmacological study
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00004232·PHASE1·Northwestern University
filgrastimcyclosporinemethylprednisoloneprednisoneallogeneic bone marrow transplantation+1 more
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00004260·PHASE1·Mayo Clinic
recombinant interleukin-12rituximab
Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00073931·PHASE2·Fred Hutchinson Cancer Center·25 enrolled
filgrastimsargramostimautologous bone marrow transplantationperipheral blood stem cell transplantationtositumomab and iodine I 131 tositumomab
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
TERMINATEDNCT00290628·NA·Masonic Cancer Center, University of Minnesota·43 enrolled
anti-thymocyte globulinbusulfancyclophosphamidecyclosporinefilgrastim+5 more
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00005804·PHASE2·Fred Hutchinson Cancer Center
cyclophosphamideallogeneic bone marrow transplantationradiation therapy
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
COMPLETEDNCT00004112·PHASE3·University of Nebraska
rituximabCHOP regimencyclophosphamidedoxorubicin hydrochlorideprednisone+1 more
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies
TERMINATEDNCT01678443·PHASE1·Fred Hutchinson Cancer Center·2 enrolled
indium In 111 anti-CD45 monoclonal antibody BC8yttrium Y 90 anti-CD45 monoclonal antibody BC8peripheral blood stem cell transplantation
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma
COMPLETEDNCT00003993·PHASE1·National Institute on Aging (NIA)·24 enrolled
aldesleukinbryostatin 1
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
TERMINATEDNCT00005787·PHASE1·Northwestern University·3 enrolled
epoetin alfafilgrastimrecombinant flt3 ligandrecombinant interleukin-3sargramostim+1 more
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
COMPLETEDNCT00005590·PHASE3·Cancer Research Campaign Clinical Trials Centre
levofloxacin
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
COMPLETEDNCT00019656·PHASE1·National Cancer Institute (NCI)
perifosine
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
COMPLETEDNCT00004075·PHASE1·Mayo Clinic
tanespimycin
UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia
COMPLETEDNCT00019838·PHASE1·National Cancer Institute (NCI)
7-hydroxystaurosporinefludarabine phosphate
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
COMPLETEDNCT00004002·PHASE1·NYU Langone Health
bortezomib
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
COMPLETEDNCT00004197·PHASE2·University of Nebraska
keyhole limpet hemocyaninsargramostimtumor cell-based vaccine therapycyclophosphamidedoxorubicin hydrochloride+3 more
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
COMPLETEDNCT00003938·PHASE3·European Organisation for Research and Treatment of Cancer - EORTC·115 enrolled
liposomal amphotericin B
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
TERMINATEDNCT00006220·PHASE1 / PHASE2·Washington University School of Medicine·5 enrolled
arsenic trioxidetretinoin
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
COMPLETEDNCT00003863·Alliance for Clinical Trials in Oncology·391 enrolled
comparative genomic hybridizationcytogenetic analysisfluorescence in situ hybridizationgene rearrangement analysis
Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
TERMINATEDNCT00019708·PHASE1·National Cancer Institute (NCI)·45 enrolled
tanespimycin
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00005092·PHASE1·M.D. Anderson Cancer Center·7 enrolled
CyclophosphamidePsoralenThiotepaAllogeneic bone marrow transplantationIn vitro-treated peripheral blood stem cell transplantation (PBSCT)+1 more
Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
TERMINATEDNCT00005993·PHASE1·Masonic Cancer Center, University of Minnesota
aldesleukinfilgrastimrecombinant human stem cell factorperipheral blood stem cell transplantation
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
COMPLETEDNCT00004061·PHASE2·Memorial Sloan Kettering Cancer Center·111 enrolled
filgrastimpalifermincyclophosphamideetoposideifosfamide+3 more
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
COMPLETEDNCT00003963·PHASE2·Jonsson Comprehensive Cancer Center·14 enrolled
rituximabvinorelbine ditartrate
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
TERMINATEDNCT00003567·PHASE1·Case Comprehensive Cancer Center·8 enrolled
filgrastimsargramostimtherapeutic autologous lymphocytesO6-benzylguaninecarmustine+2 more
Combination Chemotherapy in Treating Patients With Advanced Cancer
COMPLETEDNCT00003956·PHASE1·Memorial Sloan Kettering Cancer Center·25 enrolled
fluorouracilleucovorin calciumlonafarnib
Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00073918·PHASE2·Fred Hutchinson Cancer Center·111 enrolled
cyclophosphamideetoposideiodine I 131 tositumomabquality-of-life assessmentperipheral blood stem cell transplantation
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
COMPLETEDNCT00014391·PHASE3·Fred Hutchinson Cancer Center
palivizumabribavirin
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
COMPLETEDNCT00003874·PHASE1 / PHASE2·Fred Hutchinson Cancer Center
monoclonal antibody CD19monoclonal antibody CD20in vitro-treated peripheral blood stem cell transplantation